Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 8, 2007 - Issue 1
Journal homepage
793
Views
100
CrossRef citations to date
0
Altmetric
Original

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

Petra Kaufmann Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and SurgeonsCorrespondence[email protected]
,
Gilbero Levy Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
Jacquelina Montes Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Richaro Buchsbaum Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
Alexandra I. Barsdorf Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Vanessa Battista Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Rachel Arbing Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
Paul H. Gordon Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Hiroshi Mitsumoto Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Brvce Levin Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
John L. P. Thompson Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
for the QALS study group
,
Petra Kaufmann Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and SurgeonsCorrespondence[email protected]
,
Gilbero Levy Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
Jacquelina Montes Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Richaro Buchsbaum Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
Alexandra I. Barsdorf Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Vanessa Battista Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Rachel Arbing Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
Paul H. Gordon Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Hiroshi Mitsumoto Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center, College of Physicians and Surgeons
,
Brvce Levin Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
,
John L. P. Thompson Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
&
for the QALS study group
 show all
Pages 42-46 | Received 15 Feb 2006, Accepted 26 Jun 2006, Published online: 10 Jul 2009

Citations (100)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (25)

Christina N. Fournier, Virginia James & Jonathan D. Glass. (2023) Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 311-316.
Read now
Angela Genge & Adriano Chio. (2023) The future of ALS diagnosis and staging: where do we go from here?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 165-174.
Read now
Jenny Hamilton, Praveena Mohan, Gale Kittle & Jeremy M. Shefner. (2023) Impact of mode of training and recertification on ALSFRS-R rater performance. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 289-294.
Read now
Thomas Meyer, Susanne Spittel, Torsten Grehl, Ute Weyen, Robert Steinbach, Dagmar Kettemann, Susanne Petri, Patrick Weydt, René Günther, Petra Baum, Elena Schlapakow, Jan Christoph Koch, Matthias Boentert, Joachim Wolf, Julian Grosskreutz, Annekathrin Rödiger, Benjamin Ilse, Moritz Metelmann, Jenny Norden, Ruhan Yasemin Koc, Péter Körtvélyessy, Alessio Riitano, Bertram Walter, Barbara Hildebrandt, Friedrich Schaudinn, Christoph Münch & André Maier. (2023) Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 175-184.
Read now
Umberto Manera, Sara Cabras, Margherita Daviddi, Rosario Vasta, Maria Claudia Torrieri, Francesca Palumbo, Alessandro Bombaci, Maurizio Grassano, Luca Solero, Laura Peotta, Barbara Iazzolino, Antonio Canosa, Andrea Calvo, Adriano Chiò & Cristina Moglia. (2021) Validation of the Italian version of self-administered ALSFRS-R scale. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 151-153.
Read now
Rosa Capozzo, Stefano Zoccolella, Marco Musio, Roberta Barone, Miriam Accogli & Giancarlo Logroscino. (2020) Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 542-548.
Read now
. (2020) ALSUntangled 56: “ten red flags”-things to be wary of in alternative or off-label products. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 642-647.
Read now
Natalie James, Emma Power, Anne Hogden & Steve Vucic. (2019) Patients’ perspectives of multidisciplinary home-based e-Health service delivery for motor neurone disease. Disability and Rehabilitation: Assistive Technology 14:7, pages 737-743.
Read now
Carlayne Jackson, Mamede De Carvalho, Angela Genge, Terry Heiman-Patterson, Jeremy M. Shefner, Jenny Wei & Andrew A. Wolff. (2018) Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 506-512.
Read now
Bello Hamidou, Benoit Marin, Geraldine Lautrette, Marie Nicol, William Camu, Philippe Corcia, Marie-Christine Arnes-Bes, Christine Tranchant, Pierre Clavelou, Didier Hannequin, Giroud Maurice, Katell Beauvais, Jean-Christophe Antoine, Véronique Danel-Brunaud, Fausto Viader, Pierre-Marie Preux & Philippe Couratier. (2017) Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment*. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 519-527.
Read now
Kristen M. Allison, Yana Yunusova, Thomas F. Campbell, Jun Wang, James D. Berry & Jordan R. Green. (2017) The diagnostic utility of patient-report and speech-language pathologists’ ratings for detecting the early onset of bulbar symptoms due to ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:5-6, pages 358-366.
Read now
Elizabeth D. Bacci, Dorota Staniewska, Karin S. Coyne, Stacey Boyer, Leigh Ann White, Neta Zach & Jesse M. Cedarbaum. (2016) Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:3-4, pages 157-167.
Read now
Benoît Marin, Elisa Bianchi, Elisabetta Pupillo, Christian Lunetta, Lucio Tremolizzo, Giancarlo Logroscino, Adriano Chiò, Pierre Marie Preux & Ettore Beghi. (2016) Non-self-sufficiency as a primary outcome measure in ALS trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 77-84.
Read now
Zachary Macchi, Yunxia Wang, Dan Moore, Jonathan Katz, David Saperstein, David Walk, Ericka Simpson, Angela Genge, Tulio Bertorini, J. Americo Fernandes, Andrea Swenson, Lauren Elman, Mazen Dimachkie, Laura Herbelin, Joann Miller, Jianghua Lu, Heather Wilkins, Russell H. Swerdlow, Jeffrey Statland & Richard Barohn. (2015) A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:5-6, pages 345-352.
Read now
Helen E. Stephens, Stephanie Felgoise, Jared Young & Zachary Simmons. (2015) Multidisciplinary ALS clinics in the USA: A comparison of those who attend and those who do not. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 196-201.
Read now
Hazuki Watanabe, Naoki Atsuta, Ryoichi Nakamura, Akihiro Hirakawa, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Masahisa Katsuno, Yuishin Izumi, Mitsuya Morita, Hiroyuki Tomiyama, Akira Taniguchi, Ikuko Aiba, Koji Abe, Kouichi Mizoguchi, Masaya Oda, Osamu Kano, Koichi Okamoto, Satoshi Kuwabara, Kazuko Hasegawa, Takashi Imai, Masashi Aoki, Shoji Tsuji, Imaharu Nakano, Ryuji Kaji & Gen Sobue. (2015) Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 230-236.
Read now
Matthew Gladman, Celina Dharamshi & Lorne Zinman. (2014) Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 426-432.
Read now
David E. Thompson, Kirsten L. Gruis & Jane E. Huggins. (2014) A plug-and-play brain-computer interface to operate commercial assistive technology. Disability and Rehabilitation: Assistive Technology 9:2, pages 144-150.
Read now
Marco Caligari, Marco Godi, Simone Guglielmetti, Franco Franchignoni & Antonio Nardone. (2013) Eye tracking communication devices in amyotrophic lateral sclerosis: Impact on disability and quality of life. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:7-8, pages 546-552.
Read now
André Maier, Teresa Holm, Paul Wicks, Laura Steinfurth, Peter Linke, Christoph Münch, Robert Meyer & Thomas Meyer. (2012) Online assessment of ALS functional rating scale compares well to in-clinic evaluation: A prospective trial. Amyotrophic Lateral Sclerosis 13:2, pages 210-216.
Read now
Louisa Ng & Fary Khan. (2012) Use of the international classification of functioning, disability and health to describe patient-reported disability: A comparison of motor neurone disease, Guillain-Barré syndrome and multiple sclerosis in an Australian cohort. Disability and Rehabilitation 34:4, pages 295-303.
Read now
Jane E. Huggins, Patricia A. Wren & Kirsten L. Gruis. (2011) What would brain-computer interface users want? Opinions and priorities of potential users with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 12:5, pages 318-324.
Read now
Ettore Beghi, Adriano Chiò, Philippe Couratier, Jesùs Esteban, Orla Hardiman, Giancarlo Logroscino, Andrea Millul, Douglas Mitchell, Pierre-Marie Preux, Elisabetta Pupillo, Zorica Stevic, Robert Swingler, Bryan J. Traynor, Leonard H. Van den Berg, Jan H. Veldink & Stefano Zoccolella. (2011) The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotrophic Lateral Sclerosis 12:1, pages 1-10.
Read now
Noah Lechtzin, Nicholas J. Maragakis, Richard Kimball, Anne Busse, Virginia Hoffman & Lora Clawson. (2009) Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes. Amyotrophic Lateral Sclerosis 10:4, pages 244-247.
Read now
Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi & Gen Sobue. (2008) A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. Expert Opinion on Pharmacotherapy 9:11, pages 1845-1857.
Read now

Articles from other publishers (75)

Ava Mehdipour, Lizabeth Teshler, Vanina Dal Bello-Haas, Julie Richardson, Marla Beauchamp, John Turnbull, Marvin Chum, Wendy Johnston, Colleen O’Connell, Westerly Luth & Ayse Kuspinar. (2023) Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised (ALSFRS-R): A Rasch Analysis. Physical Therapy 103:11.
Crossref
Lev Brylev, V. S. Demeshonok, A. I. Ataulina, M. O. Kovalchuk, D. S. Druzhinin & A. B. Guekht. (2023) Validity and reliability of the Russian version of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R). Neurological Sciences.
Crossref
Reza Boostani, Nahid Olfati, Hosein Shamshiri, Zanireh Salimi, Farzad Fatehi, Seyed Arya Hedjazi, Atefeh Fakharian, Majid Ghasemi, Ali Asghar Okhovat, Keivan Basiri, Bahram Haghi Ashtiani, Behnaz Ansari, Gholam Reza Raissi, Seyed Ahmadreza Khatoonabadi, Payam Sarraf, Sara Movahed, Akram Panahi, Bentolhoda Ziaadini, Mohammad Yazdchi, Jalal Bakhtiyari & Shahriar Nafissi. (2023) Iranian clinical practice guideline for amyotrophic lateral sclerosis. Frontiers in Neurology 14.
Crossref
André Maier, Christoph Münch & Thomas Meyer. (2023) Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose. Klinische Neurophysiologie 54:01, pages 28-34.
Crossref
Shotaro Haji, Koji Fujita, Ryosuke Oki, Yusuke Osaki, Ryosuke Miyamoto, Hiroyuki Morino, Seiichi Nagano, Naoki Atsuta, Yuki Kanazawa, Yuki Matsumoto, Atsuko Arisawa, Hisashi Kawai, Yasutaka Sato, Satoshi Sakaguchi, Kenta Yagi, Tatsuto Hamatani, Tatsuo Kagimura, Hiroaki Yanagawa, Hideki Mochizuki, Manabu Doyu, Gen Sobue, Masafumi Harada & Yuishin Izumi. (2023) An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study. JMIR Research Protocols 12, pages e42032.
Crossref
Gizem Gül Koc, Fatih Safa Eranay, Ali Kokangul & Filiz Koc. (2023) Determining the Significance Weights of ALSFRS-R Items Using Analytic Hierarchy Process. Neurological Sciences and Neurophysiology 40:2, pages 88-94.
Crossref
André Maier, Matthias Boentert, Peter Reilich, Simon Witzel, Susanne Petri, Julian Großkreutz, Moritz Metelmann, Paul Lingor, Isabell Cordts, Johannes Dorst, Daniel Zeller, René Günther, Tim Hagenacker, Torsten Grehl, Susanne Spittel, Joachim Schuster, Albert Ludolph & Thomas Meyer. (2022) ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale. Neurological Research and Practice 4:1.
Crossref
Jacqueline Montes, Katy J. Eichinger, Amy Pasternak, Cara Yochai & Kristin J. Krosschell. (2022) A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities. Orphanet Journal of Rare Diseases 17:1.
Crossref
Susan L. Hartmaier, Thomas Rhodes, Suzanne F. Cook, Courtney Schlusser, Chao Chen, Steve Han, Neta Zach, Venkatesha Murthy & Shreya Davé. (2022) Qualitative measures that assess functional disability and quality of life in ALS. Health and Quality of Life Outcomes 20:1.
Crossref
Charis Wong, Rachel S Dakin, Jill Williamson, Judith Newton, Michelle Steven, Shuna Colville, Maria Stavrou, Jenna M Gregory, Elizabeth Elliott, Arpan R Mehta, Jeremy Chataway, Robert J Swingler, Richard Anthony Parker, Christopher J Weir, Nigel Stallard, Mahesh K B Parmar, Malcolm R Macleod, Suvankar Pal & Siddharthan Chandran. (2022) Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease. BMJ Open 12:7, pages e064173.
Crossref
Michelle J. Sanfilippo, Mary E. Layshock & Leslie Keniston. (2022) Exploring the association between outcome measures to guide clinical management in patients with amyotrophic lateral sclerosis. Journal of Physical Therapy Science 34:8, pages 532-539.
Crossref
Leonor Cerdá Alberich, Juan Francisco Vázquez-Costa, Amadeo Ten-Esteve, Miguel Mazón & Luis Martí-Bonmatí. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers 507 548 .
Can Sun, Christina N. Fournier, Shan Ye, Nan Zhang, Yan Ma & Dongsheng Fan. (2021) Chinese validation of the Rasch‐Built Overall Amyotrophic Lateral Sclerosis Disability Scale. European Journal of Neurology 28:6, pages 1876-1883.
Crossref
Stanisław Maksymowicz, Paula Kukołowicz, Tomasz Siwek & Agnieszka Rakowska. (2020) Validation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale in Poland and its reliability in conditions of the medical experiment. Neurological Sciences 42:3, pages 943-949.
Crossref
Keith R. Spencer, Zachariah W. Foster, Nazifa Abdul Rauf, Latease Guilderson, Derek Collins, James G. Averill, Sean E. Walker, Ian Robey, Jonathan D. Cherry, Victor E. Alvarez, Bertrand R. Huber, Ann C. McKee, Neil W. Kowall, Christopher B. Brady & Thor D. Stein. (2020) Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans. Brain Pathology 30:6, pages 1028-1040.
Crossref
Judith Newton, Kiran Jayaprakash, Stella A. Glasmacher, Alison McEleney, Andrew Bethell, Elizabeth Fraser, Janice Hatrick, Hanne Haagenrud, Gill Stott, Rachel Dakin, Siddharthan Chandran & Suvankar Pal. (2020) Excellent reliability of the ALSFRS-R administered via videoconferencing: A study of people with motor neuron disease in Scotland. Journal of the Neurological Sciences 416, pages 116991.
Crossref
Raghav Govindarajan, James D. Berry, Sabrina Paganoni, Michael T. Pulley & Zachary Simmons. (2020) Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle & Nerve 62:3, pages 321-326.
Crossref
Jinsy A. Andrews, James D. Berry, Robert H. Baloh, Nathan Carberry, Merit E. Cudkowicz, Brixhilda Dedi, Jonathan Glass, Nicholas J. Maragakis, Timothy M. Miller, Sabrina Paganoni, Jeffrey D. Rothstein, Jeremy M. Shefner, Zachary Simmons, Michael D. Weiss & Richard S. Bedlack. (2020) Amyotrophic lateral sclerosis care and research in the United States during the COVID ‐19 pandemic: Challenges and opportunities . Muscle & Nerve 62:2, pages 182-186.
Crossref
Heather Anne Hayes, Nan Hu, Xuechen Wang, Summer Gibson, Pamela Mathy, Kiera Berggren & Mark Bromberg. (2020) Comparison of driving capacity among patients with amyotrophic lateral sclerosis and healthy controls using the lane change task. Journal of the Neurological Sciences 413, pages 116741.
Crossref
Marie-Louise Zeissler, Vivien Li, Mahesh K.B. Parmar & Camille Buchholz Carroll. (2020) Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer. Journal of Parkinson's Disease 10:2, pages 413-428.
Crossref
Christina N. Fournier, Richard Bedlack, Colin Quinn, James Russell, Diane Beckwith, Kathleen H. Kaminski, William Tyor, Vicki Hertzberg, Virginia James, Meraida Polak & Jonathan D. Glass. (2020) Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS). JAMA Neurology 77:4, pages 480.
Crossref
Hiroshi Mitsumoto, Codruta Chiuzan, Madison Gilmore, Yuan Zhang, Zachary Simmons, Sabrina Paganoni, Yasushi Y. Kisanuki, Lorne Zinman, Omar Jawdat, Eric Sorenson, Mary Kay Floeter, Erik P. Pioro, J. Americo M. Fernandes Filho, Daragh Heitzman, Christina Nicole Fournier, Bjorn Oskarsson, Terry Heiman‐Patterson, Nicholas Maragakis, Nanette Joyce, Ghazala Hayat, Sharon Nations, Stephen Scelsa, David Walk, Lauren Elman, Jonathan Hupf & Brittany McHale. (2019) Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale. Muscle & Nerve 61:2, pages 163-172.
Crossref
Leonhard A Bakker, Carin D Schröder, Harold H G Tan, Simone M A G Vugts, Ruben P A van Eijk, Michael A van Es, Johanna M A Visser-Meily & Leonard H van den Berg. (2020) Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R. Journal of Neurology, Neurosurgery & Psychiatry 91:1, pages 75-81.
Crossref
Anne Marie Wills, Jamie Garry, Jane Hubbard, Taylor Mezoian, Christopher T. Breen, Courtney Ortiz-Miller, Paige Nalipinski, Stacey Sullivan, James D. Berry, Merit Cudkowicz, Sabrina Paganoni, James Chan & Eric A. Macklin. (2019) Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. BMC Neurology 19:1.
Crossref
Jiaoting Jin, Fangfang Hu, Qiuli Zhang, Qiaoyi Chen, Haining Li, Xing Qin, Rui Jia, Li Kang, Yonghui Dang & Jingxia Dang. (2019) Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis. Scientific Reports 9:1.
Crossref
Agessandro Abrahao, Ying Meng, Maheleth Llinas, Yuexi Huang, Clement Hamani, Todd Mainprize, Isabelle Aubert, Chinthaka Heyn, Sandra E. Black, Kullervo Hynynen, Nir Lipsman & Lorne Zinman. (2019) First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound. Nature Communications 10:1.
Crossref
Yana Yunusova, Emily K. Plowman, Jordan R. Green, Carolina Barnett & Peter Bede. (2019) Clinical Measures of Bulbar Dysfunction in ALS. Frontiers in Neurology 10.
Crossref
Sapna Pathak, James B. Caress, Marlena Wosiski-Kuhn, Carol Milligan, Delaney Williams & Michael S. Cartwright. (2019) A pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis. Muscle & Nerve 59:2, pages 181-186.
Crossref
Jordan R. Green, Kristen M. Allison, Claire Cordella, Brian D. Richburg, Gary L. Pattee, James D. Berry, Eric A. Macklin, Erik P. Pioro & Richard A. Smith. (2018) Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis. British Journal of Clinical Pharmacology 84:12, pages 2849-2856.
Crossref
Gabriel S Walt, Hannah M Burris, Christopher B Brady, Keith R Spencer, Victor E Alvarez, Bertrand R Huber, Latease Guilderson, Nazifa Abdul Rauf, Derek Collins, Tarnjit Singh, Rebecca Mathias, James G Averill, Sean E Walker, Ian Robey, Ann C McKee, Neil W Kowall & Thor D Stein. (2018) Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort. Journal of Neuropathology & Experimental Neurology 77:12, pages 1091-1100.
Crossref
Maria O. Kovalchuk, Jules A.A.C. Heuberger, Boudewijn T.H.M. Sleutjes, Dimitrios Ziagkos, Leonard H. van den Berg, Toby A. Ferguson, Hessel Franssen & Geert Jan Groeneveld. (2018) Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. Clinical Pharmacology & Therapeutics 104:6, pages 1136-1145.
Crossref
Kaila L. Stipancic, Yana Yunusova, James D. Berry & Jordan R. Green. (2018) Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral Sclerosis. Journal of Speech, Language, and Hearing Research 61:11, pages 2757-2771.
Crossref
Michael Lee & Alana McCambridge. (2018) Clinimetrics: Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R). Journal of Physiotherapy 64:4, pages 269-270.
Crossref
Jake Plewa, Abhilasha Surampalli, Marie Wencel, Merit Milad, Sandra Donkervoort, Vincent J. Caiozzo, Namita Goyal, Tahseen Mozaffar & Virginia Kimonis. (2018) A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene. Neuromuscular Disorders 28:9, pages 778-786.
Crossref
Christoph Neuwirth, Nathalie Braun, Kristl G. Claeys, Robert Bucelli, Christina Fournier, Mark Bromberg, Susanne Petri, Stephan Goedee, Timothée Lenglet, Ron Leppanen, Antonio Canosa, Ira Goodman, Muhammad Al-Lozi, Takuya Ohkubo, Annemarie Hübers, Nazem Atassi, Agessandro Abrahao, Andreas Funke, Martin Appelfeller, Anke Tümmler, Eoin Finegan, Jonathan D. Glass, Suma Babu, Shafeeq S. Ladha, Olga Kwast-Rabben, Raul Juntas-Morales, Amina Coffey, Vinay Chaudhry, Tuan Vu, Chow Saephanh, Colleen Newhard, Marion Zakrzewski, Esther Rosier, Nancy Hamel, Divisha Raheja, Jesper Raaijman, Toby Ferguson & Markus Weber. (2018) Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres. Clinical Neurophysiology 129:8, pages 1756-1762.
Crossref
Foteini Christidi, Efstratios Karavasilis, Georgios Velonakis, Panagiotis Ferentinos, Michail Rentzos, Nikolaos Kelekis, Ioannis Evdokimidis & Peter Bede. (2018) The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 9.
Crossref
Leonhard A. Bakker, Carin D. Schröder, Michael A. van Es, Paul Westers, Johanna M. A. Visser-Meily & Leonard H. van den Berg. (2017) Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model. Journal of Neurology 264:7, pages 1413-1420.
Crossref
Christoph Neuwirth, Paul E. Barkhaus, Christian Burkhardt, José Castro, David Czell, Mamede de Carvalho, Sanjeev Nandedkar, Erik Stålberg & Markus Weber. (2017) Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in Amyotrophic Lateral Sclerosis. Clinical Neurophysiology 128:3, pages 495-500.
Crossref
Stephan Grimaldi, Lauréline Duprat, Aude-Marie Grapperon, Annie Verschueren, Emilien Delmont & Shahram Attarian. (2017) Global motor unit number index sum score for assessing the loss of lower motor neurons in amyotrophic lateral sclerosis. Muscle & Nerve.
Crossref
Sanjana Shellikeri, Jordan R. Green, Madhura Kulkarni, Panying Rong, Rosemary Martino, Lorne Zinman & Yana Yunusova. (2016) Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis. Journal of Speech, Language, and Hearing Research 59:5, pages 887-899.
Crossref
Hazuki Watanabe, Naoki Atsuta, Akihiro Hirakawa, Ryoichi Nakamura, Masahiro Nakatochi, Shinsuke Ishigaki, Aritoshi Iida, Shiro Ikegawa, Michiaki Kubo, Daichi Yokoi, Hirohisa Watanabe, Mizuki Ito, Masahisa Katsuno, Yuishin Izumi, Mitsuya Morita, Kazuaki Kanai, Akira Taniguchi, Ikuko Aiba, Koji Abe, Koichi Mizoguchi, Masaya Oda, Osamu Kano, Koichi Okamoto, Satoshi Kuwabara, Kazuko Hasegawa, Takashi Imai, Akihiro Kawata, Masashi Aoki, Shoji Tsuji, Kenji Nakashima, Ryuji Kaji & Gen Sobue. (2016) A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN . Journal of Neurology, Neurosurgery & Psychiatry 87:8, pages 851-858.
Crossref
Daichi Yokoi, Naoki Atsuta, Hazuki Watanabe, Ryoichi Nakamura, Akihiro Hirakawa, Mizuki Ito, Hirohisa Watanabe, Masahisa Katsuno, Yuishin Izumi, Mitsuya Morita, Akira Taniguchi, Masaya Oda, Koji Abe, Kouichi Mizoguchi, Osamu Kano, Satoshi Kuwabara, Ryuji Kaji & Gen Sobue. (2016) Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis. Journal of Neurology 263:6, pages 1129-1136.
Crossref
Jessica Mandrioli, Sara Biguzzi, Carlo Guidi, Elisabetta Sette, Emilio Terlizzi, Alessandro Ravasio, Mario Casmiro, Fabrizio Salvi, Rocco Liguori, Romana Rizzi, Vladimiro Pietrini, Annamaria Borghi, Rita Rinaldi, Nicola Fini, Elisabetta Chierici, Mario Santangelo, Enrico Granieri, Vittoria Mussuto, Silvia De Pasqua, Eleni Georgoulopoulou, Antonio Fasano, Salvatore Ferro & Roberto D’Alessandro. (2015) Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy. Neurological Sciences 36:12, pages 2243-2252.
Crossref
Seward B. Rutkove. (2015) Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis. Neurotherapeutics 12:2, pages 384-393.
Crossref
Hyun Young Kim, Heejaung Kim, Ki-Wook Oh, Seong-Il Oh, Seong-Ho Koh, Wonki Baik, Min Young Noh, Kyung Suk Kim & Seung Hyun Kim. (2014) Biological Markers of Mesenchymal Stromal Cells as Predictors of Response to Autologous Stem Cell Transplantation in Patients With Amyotrophic Lateral Sclerosis: An Investigator-Initiated Trial and In Vivo Study. Stem Cells 32:10, pages 2724-2731.
Crossref
Sabrina Paganoni, Merit Cudkowicz & James D Berry. (2014) Outcome measures in amyotrophic lateral sclerosis clinical trials. Clinical Investigation 4:7, pages 605-618.
Crossref
Ryoichi Nakamura, Naoki Atsuta, Hazuki Watanabe, Akihiro Hirakawa, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Masahisa Katsuno, Fumiaki Tanaka, Yuishin Izumi, Mitsuya Morita, Kotaro Ogaki, Akira Taniguchi, Ikuko Aiba, Koichi Mizoguchi, Koichi Okamoto, Kazuko Hasegawa, Masashi Aoki, Akihiro Kawata, Koji Abe, Masaya Oda, Masaaki Konagaya, Takashi Imai, Masanori Nakagawa, Shoji Tsuji, Ryuji Kaji, Imaharu Nakano & Gen Sobue. (2013) Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients. Journal of Neurology, Neurosurgery & Psychiatry 84:12, pages 1365-1371.
Crossref
Franco Franchignoni, Gabriele Mora, Andrea Giordano, Paolo Volanti & Adriano Chiò. (2013) Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. Journal of Neurology, Neurosurgery & Psychiatry 84:12, pages 1340-1345.
Crossref
Christina Schuster, Elisabeth Kasper, Judith Machts, Daniel Bittner, Jörn Kaufmann, Reiner Benecke, Stefan Teipel, Stefan Vielhaber & Johannes Prudlo. (2013) Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. Journal of Neurology 260:11, pages 2856-2864.
Crossref
Susanne Abdulla, Stefan Vielhaber, Sonja Körner, Judith Machts, Hans-Jochen Heinze, Reinhard Dengler & Susanne Petri. (2013) Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure. Journal of Neurology 260:9, pages 2242-2255.
Crossref
P. Bede, A. Bokde, M. Elamin, S. Byrne, R. L. McLaughlin, N. Jordan, H. Hampel, L. Gallagher, C. Lynch, A. J. Fagan, N. Pender & O. Hardiman. (2012) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. Journal of Neurology, Neurosurgery & Psychiatry 84:7, pages 766-773.
Crossref
Louisa Ng & Fary Khan. (2013) International classification of functioning, disability and health and motor neurone disease rehabilitation. Social Care and Neurodisability 4:1, pages 29-41.
Crossref
Matthew Gladman, Merit Cudkowicz & Lorne Zinman. (2012) Enhancing clinical trials in neurodegenerative disorders. Current Opinion in Neurology 25:6, pages 735-742.
Crossref
Nazem Atassi, David Schoenfeld & Merit Cudkowicz. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology 273 283 .
. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology 215 308 .
Dan H Moore, Jonathan S Katz & Robert G Miller. (2011) A review of clinical trial designs in amyotrophic lateral sclerosis. Neurodegenerative Disease Management 1:6, pages 481-490.
Crossref
Ammar Al-Chalabi, Pamela J Shaw, Carolyn A Young, Karen E Morrison, Caroline Murphy, Marie Thornhill, Joanna Kelly, I Nicholas Steen & P Nigel Leigh. (2011) Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]. BMC Neurology 11:1.
Crossref
Merit Cudkowicz, Michael E Bozik, Evan W Ingersoll, Robert Miller, Hiroshi Mitsumoto, Jeremy Shefner, Dan H Moore, David Schoenfeld, James L Mather, Donald Archibald, Mary Sullivan, Craig Amburgey, Juliet Moritz & Valentin K Gribkoff. (2011) The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nature Medicine 17:12, pages 1652-1656.
Crossref
Louisa Ng, Kirk Kee, Bhasker Amatya & Fary Khan. (2011) Patient/carer perceptions of disability in motor neurone disease and carer coping. International Journal of Therapy and Rehabilitation 18:10, pages 568-578.
Crossref
Louisa Ng, Paul Talman & Fary Khan. (2011) Neuropsychological sequelae in motor neurone disease: outcomes of a peer support programme. International Journal of Therapy and Rehabilitation 18:8, pages 429-437.
Crossref
Lorne Zinman & Merit Cudkowicz. (2011) Emerging targets and treatments in amyotrophic lateral sclerosis. The Lancet Neurology 10:5, pages 481-490.
Crossref
Kirsten L. Gruis, Patricia A. Wren & Jane E. Huggins. (2011) Amyotrophic lateral sclerosis patients' self‐reported satisfaction with assistive technology. Muscle & Nerve 43:5, pages 643-647.
Crossref
Louisa Ng & Fary Khan. (2011) Identification of Personal Factors in Motor Neurone Disease: A Pilot Study. Rehabilitation Research and Practice 2011, pages 1-7.
Crossref
Sanjeev D. Nandedkar, Paul E. Barkhaus & Erik V. StÅlberg. (2010) Motor unit number index (MUNIX): principle, method, and findings in healthy subjects and in patients with motor neuron disease. Muscle & Nerve 42:5, pages 798-807.
Crossref
Christoph Neuwirth, Sanjeev Nandedkar, Erik StåLberg & Markus Weber. (2010) Motor unit number index (MUNIX): A novel neurophysiological technique to follow disease progression in amyotrophic lateral sclerosis. Muscle & Nerve 42:3, pages 379-384.
Crossref
D. Keizman, M. Ish-Shalom, S. Berliner, N. Maimon, Y. Vered, I. Artamonov, J. Tsehori, B. Nefussy & V.E. Drory. (2009) Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?. Journal of the Neurological Sciences 285:1-2, pages 95-99.
Crossref
Jacqueline MontesAndrew M. Gordon, Shree Pandya, Darryl C. De Vivo & Petra Kaufmann. (2009) Clinical Outcome Measures in Spinal Muscular Atrophy. Journal of Child Neurology 24:8, pages 968-978.
Crossref
Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen‐Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven P. Novella, Terry Heiman‐Patterson, Edward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra Barsdorf, Hiroshi Mitsumoto & Bruce Levin. (2009) Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Annals of Neurology 66:2, pages 235-244.
Crossref
P. Wicks, M. P. Massagli, C. Wolf & J. Heywood. (2009) Measuring function in advanced ALS: validation of ALSFRS-EX extension items. European Journal of Neurology 16:3, pages 353-359.
Crossref
Gil I. Wolfe, Richard J. Barohn, Donald B. Sanders & Michel P. McDermott. (2008) Comparison of outcome measures from a trial of Mycophenolate mofetil in myasthenia gravis. Muscle & Nerve 38:5, pages 1429-1433.
Crossref
Maryam Oskoui & Petra Kaufmann. (2008) Spinal muscular atrophy. Neurotherapeutics 5:4, pages 499-506.
Crossref
Jeremy M. Shefner. (2008) Designing Clinical Trials in Amyotrophic Lateral Sclerosis. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 495-508.
Crossref
T. Meyer, J.S. Dullinger, C. Münch, J.-P. Keil, E. Hempel, S. Rosseau, N. Borisow & P. Linke. (2008) Elektive Termination der Beatmungstherapie bei der amyotrophen LateralskleroseElective termination of respiratory therapy in amyotrophic lateral sclerosis. Der Nervenarzt 79:6, pages 684-690.
Crossref
Letizia Mazzini, Katia Mareschi, Ivana Ferrero, Elena Vassallo, Giuseppe Oliveri, Nicola Nasuelli, Gaia Donata Oggioni, Lucia Testa & Franca Fagioli. (2008) Stem cell treatment in Amyotrophic Lateral Sclerosis. Journal of the Neurological Sciences 265:1-2, pages 78-83.
Crossref
Jacqueline Montes, Caterina Bendotti, Massimo Tortarolo, Cristina Cheroni, Hussein Hallak, Zipora Speiser, Sari Goren, Eran Blaugrund & Paul H. Gordon. 2008. Animal and Translational Models for CNS Drug Discovery. Animal and Translational Models for CNS Drug Discovery 267 310 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.